Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EHSG-KF (denovoSkin) vs STSG for Severe Burns
NCT03227146Phase 2Completed
- Sponsor
- CUTISS
- Start
- Oct 2017
- Primary completion
- Nov 2022
- Modality
- Implantable Devices, Implantable Hydrogels, Cell Therapies
- Countries
- 3
01
Overview
A Phase 2 trial of denovoSkin in burn injury, sponsored by CUTISS. Started Oct 2017; status: completed.
02
Drugs
denovoSkin
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT03227146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03227146.